Phosphodiesterase Inhibitors Market: Industry Analysis and Opportunity Assessment 2028 – Benzinga – Benzinga

New York, United States, Wed, 30 Mar 2022 04:54:53 / Comserve Inc. / — Phosphodiesterase (PDE) inhibitors are termed as therapeutic agents that target PDE isoenzymes and prevents the metabolism of the secondary messengers (cyclic adenosine monophosphate, cyclic guanosine monophosphate) and prolonging the biological effect.

Research Nester published a report titled Phosphodiesterase Inhibitors Market: Global Demand Analysis & Opportunity Outlook 2028″which delivers a detailed overview of the phosphodiesterase inhibitors market in terms of market segmentation by drug class, type, application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis, and Porter’s five force model.
Phosphodiesterase (PDE) inhibitors are termed as therapeutic agents that target PDE isoenzymes and prevents the metabolism of the secondary messengers (cyclic adenosine monophosphate, cyclic guanosine monophosphate) and prolonging the biological effect. Theophylline and papaverine are the two broadly used non-selective phosphodiesterase enzyme inhibitors and are widely accepted to treat various diseases such as cardiovascular, respiratory, and erectile dysfunction.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-2634
The global phosphodiesterase inhibitors market is segmented by application into respiratory disease, erectile dysfunction, vascular disease, diabetes and others, out of which, the erectile dysfunction sub-segment is anticipated to hold leading shares in the phosphodiesterase inhibitors market on the back of the growing concern for the increasing number of patients that have erectile dysfunction disease and the growing incidences of diseases such as diabetes mellitus, testosterone deficiency, prostate cancer, obesity, hypertension, hyperlipidemia. It is to be noted here that consumption of certain medicines and substance abuse are some of the major factors that can lead to erectile dysfunction, thereby raising the need for the greater application of phosphodiesterase inhibitors in the treatment of erectile dysfunction.
Regionally, the phosphodiesterase inhibitors market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America is projected to account for the highest share of the phosphodiesterase inhibitors market throughout the forecast period on account of factors such as the presence of large pharmaceutical companies and increasing lifestyle changes are contributing to the phosphodiesterase inhibitors market growth in the region.
Rising Prevalence Of Chronic Disease And Erectile Dysfunction
Factors such as rising expenditure for the treatment of chronic diseases, coupled with escalating the prevalence of erectile dysfunction and growing concern for the chronic diseases such as heart disease, stroke, diabetes, and prediabetes amongst individuals worldwide are estimated to drive the market over the forecast period.
However, potential drug interactions of PDE inhibitors, side-effects associated with PDE inhibitors, and the launch of generics are expected to operate as key restraint to the growth of phosphodiesterase inhibitors market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the phosphodiesterase inhibitors market which includes company profiling of Bayer AG BAYN, Eli Lilly and Co. BAYN, GlaxoSmithKline Plc GSK, Pfizer Inc. PFE, Vivus Inc VVUSQ, AstraZeneca plc AZN, and Celgene Corporation CELG. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the phosphodiesterase inhibitors market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
Get Exclusive Sample Report Copy Of This Report @ https://www.researchnester.com/sample-request-2634
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
For more information, please contact:
Research Nester
Email: info@researchnester.com
Tel: +1-6465869123
The post Phosphodiesterase Inhibitors Market: Industry Analysis and Opportunity Assessment 2028 appeared first on Comserveonline.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

source

Leave a Comment

Your email address will not be published.

Shopping Cart